Skip to main content
NIH Clinical Center
  Home | Contact Us | Site Map | Search
About the Clinical Center
For Researchers and Physicians
Participate in Clinical Studies

Back to: Clinical Center Home Page > About the Clinical Center > Senior Staff
 
Senior Staff

Joseph Kovacs, MD
Senior Investigator and Head
AIDS Section
Critical Care Medicine Department

Academic Degrees
B.A., Harvard University
M.D., Cornell University Medical College

Email: jkovacs@cc.nih.gov

Phone: 301-496-9907

Portrait of Joseph Kovacs

Biosketch

Dr. Joseph Kovacs is a senior investigator in the Clinical Center’s Critical Care Medicine Department at the National Institutes of Health. Since 1987, he has served as head of CCMD’s AIDS Section. He also is an associate clinical professor of medicine at the George Washington University School of Medicine and Health Sciences.

Dr. Kovacs completed his undergraduate degree at Harvard University and obtained his medical degree from Cornell University Medical College. After an internship and residency at New York Hospital, he came to the CC in 1982 for fellowships in infectious diseases and critical care.

Dr. Kovacs’s research interests include the treatment and prevention of HIV infection, acquired immunodeficiency syndrome (AIDS), Pneumocystis carinii pneumonia, and Toxoplasma gondii infection.

He currently is active in several societies and organizations, including the American Society for Clinical Investigation (elected to membership in 1994) and the Association of American Physicians (elected in 1998). He has served on several editorial boards of professional journals in infectious diseases and drug resistance, including currently as associate editor of Journal of Infectious Diseases.

Honors and Awards

NIH Bench-to-Bedside Research Award, 2007-2008, 2006-2007, and 2005-2006; Clinical Center Director’s Award, 1999; U.S. Public Health Service Outstanding Unit Citation, 1995, and Outstanding Service Medal, 1995; Young Investigator Award, American Federation for Clinical Research (Eastern Region), 1993; USPHS Unit Commendation, 1991, Commendation Medal, 1990, and Incentive Award for Scientific Achievement, 1989; Young Investigator Award, Society of Critical Care Medicine, 1988; Alpha Omega Alpha

Selected Publications

BOOKS/BOOK CHAPTERS AND JOURNAL REVIEWS

Walworth CM, Tavel JA, and Kovacs JA. “Treatment and prevention of opportunistic infections in patients with human immunodeficiency virus infection” in Advances in Internal Medicine, Volume 41. Schrier RW, ed. Mosby Year Book, Inc. Chicago, IL, 1996.

Kovacs JA. Diagnosis of P. carinii pneumonia. In Shelhamer JH, moderator. The laboratory evaluation of pulmonary opportunistic infections. Ann. Intern. Med. 124: 585-599, 1996.

Kovacs JA and Masur H. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. N. Engl. J. Med. 342:1416-29, 2000.

Kovacs JA, Gill VJ, Meshnick S, and Masur H. New insights into transmission, diagnosis, and drug treatment of P. carinii pneumonia. JAMA 286: 2450-2460, 2001.

Miller KD, Kuruppu J, and Kovacs JA. Interleukin-2, Chapter 2 (p15-44) in SM Holland, Ed. Cytokine Therapeutics in Infectious Diseases, Lippincott Williams and Wilkins, Philadelphia, PA. 2001.

Kovacs JA. General Immune-based Therapies in the Management of HIV-infected Patients. in “AIDS Therapy”, 2nd edition. ed. Dolin R, Masur H, and Saag MS. Churchill Livingstone, Inc., New York, NY. 2003.

Kottilil S, Polis MA, and Kovacs JA. HIV Infection, HCV Infection and HAART: Difficult clinical decisions. JAMA. 292: 243-50, 2004

Larsen HH, Masur H, and Kovacs JA. 2005. Current Regimens For Treatment And Prophylaxis of Pneumocystis jiroveci Pneumonia. In Cushion MT and Walzer PD (ed). Pneumocystis Pneumonia, 3rd ed. Marcell Dekker, New York.

Montoya J, Kovacs JA, and Remington JS. Toxoplasma gondii. In “Mandell Douglas, and Bennett’s Principles and Practice of Infectious Diseases”, 6th edition. Ed. Mandell GL, Bennett JE, and Dolin R. Churchill Livingstone, Inc., New York, NY (2005).

Morse CG, and Kovacs JA. Metabolic and Skeletal Complications of HIV Infection: The Price of Success. JAMA. 296:844-854, 2006.

JOURNAL ARTICLES

Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer JH, Lane HC, Urmacher C, Honig C, Longo DL, Parker MM, Natanson C, Parrillo JE, Fauci AS, Pizzo PA, and Masur H: Pnemocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100:663-671, 1984.

Kovacs JA, Ng V, Masur H, Leoung G, Hadley WK, Evans G, Lane HC, Ognibene FP, Shelhamer JH, Parrillo JE, and Gill VJ: Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med 318:589-593, 1988.

Lundgren B, Lipschik GY and Kovacs JA. Purification and characterization of a major human P. carinii surface antigen. J. Clin. Invest. 87:163-170, 1991.

Lipschik GY, Gill VJ, Lundgren J, Andrawis VA, Nelson NA, Nielsen JO, Ognibene FP, and Kovacs JA. Improved diagnosis of P. carinii infection by polymerase chain reaction in induced sputum and blood. Lancet. 340:203-206, 1992

Angus CW, Tu A, Vogel P, Qin M, and Kovacs JA. Expression of variants of the major surface glycoprotein of P. carinii. J Exp. Med.183:1229-1234, 1996.

Kovacs JA, Vogel S, Albert JM, Falloon J, Davey RT,Jr., Walker RE, Polis MA, Spooner K, Metcalf JA, Baseler M, Fyfe G, Dewar RJ, Masur H, and Lane HC. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 335: 1350-1356, 1996.

Ma L, Borio L, Masur H, and Kovacs JA. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J. Infect. Dis. 180: 1969 -1978, 1999.

Kovacs JA, Lempicki RA, Sidorov I, Adelsberger JW, Herpin B, Metcalf JA, Polis MA, Davey RT, Tavel J, Falloon J, Stevens R, Lambert L, Dewar R, Schwartzentruber DJ, Anver MR, Baseler MW, Masur H, Dimitrov DS, and Lane HC. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV J. Exp. Med. 194:7131-1741, 2001.

Kovacs JA, Lempicki RA, Sidorov I, Adelsberger JW, Sereti I, Sachau W, Kelly G, Metcalf JA, Davey RT, Falloon J, Polis MA, Tavel J, Stevens R, Lambert L, Hosack DA, Bosche M, Issaq HJ, Fox SD, Leitman S, Baseler MW, Masur H, Di Mascio M, Dimitrov DS, and Lane HC. Induction of Prolonged Survival of CD4+ T Lymphocytes by Intermittent IL-2 Therapy in HIV-infected Patients. J. Clin. Invest. 115:2139-2148, 2005.

Morse CG, Mican JM, Jones EC, Joe GO, Rick ME, Formentini E, Kovacs JA. The Incidence and Natural History of Osteonecrosis in HIV-Infected Adults. Clin Infect Dis 44:739-48, 2007. Epub 2007 Jan 23.

This page last reviewed on 06/30/08



National Institutes
of Health
  Department of Health
and Human Services
 
NIH Clinical Center National Institutes of Health